| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2179 | 2017 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 483 | 2022 |
| Prevalence, detection, management, and control of hypertension in Ashanti, West Africa FP Cappuccio, FB Micah, L Emmett, SM Kerry, S Antwi, R Martin-Peprah, ... Hypertension 43 (5), 1017-1022, 2004 | 474 | 2004 |
| Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans S Etuaful, B Carbonnelle, J Grosset, S Lucas, C Horsfield, R Phillips, ... Antimicrobial agents and chemotherapy 49 (8), 3182-3186, 2005 | 329 | 2005 |
| Mycobacterium ulcerans disease TS van der Werf, Y Stienstra, RC Johnson, R Phillips, O Adjei, B Fleischer, ... Bulletin of the World Health Organization 83, 785-791, 2005 | 225 | 2005 |
| A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa E Wilkinson, M Giovanetti, H Tegally, JE San, R Lessells, D Cuadros, ... Science 374 (6566), 423-431, 2021 | 217 | 2021 |
| Buruli ulcer: emerging from obscurity M Wansbrough-Jones, R Phillips The Lancet 367 (9525), 1849-1858, 2006 | 210 | 2006 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The lancet Gastroenterology & hepatology 8 (10), 879-907, 2023 | 191 | 2023 |
| Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of Mycobacterium ulcerans Disease FS Sarfo, R Phillips, K Asiedu, E Ampadu, N Bobi, E Adentwe, A Lartey, ... Antimicrobial agents and chemotherapy 54 (9), 3678-3685, 2010 | 159 | 2010 |
| Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana AM Geretti, M Patel, FS Sarfo, D Chadwick, J Verheyen, M Fraune, ... Journal of clinical microbiology 48 (9), 3223-3230, 2010 | 133 | 2010 |
| Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis AJ Stockdale, M Chaponda, A Beloukas, RO Phillips, PC Matthews, ... The Lancet Global Health 5 (10), e992-e1003, 2017 | 131 | 2017 |
| Hypertension and renal failure in Kumasi, Ghana J Plange-Rhule, R Phillips, JW Acheampong, AK Saggar-Malik, ... Journal of human hypertension 13 (1), 37-40, 1999 | 125 | 1999 |
| The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance H Tegally, JE San, M Cotten, M Moir, B Tegomoh, G Mboowa, DP Martin, ... Science 378 (6615), eabq5358, 2022 | 123 | 2022 |
| Sensitivity of PCR Targeting the IS2404 Insertion Sequence of Mycobacterium ulcerans in an Assay Using Punch Biopsy Specimens for Diagnosis of Buruli Ulcer R Phillips, C Horsfield, S Kuijper, A Lartey, I Tetteh, S Etuaful, ... Journal of clinical microbiology 43 (8), 3650-3656, 2005 | 122 | 2005 |
| Buruli ulcer: a review of the current knowledge RR Yotsu, K Suzuki, RE Simmonds, R Bedimo, A Ablordey, ... Current tropical medicine reports 5, 247-256, 2018 | 113 | 2018 |
| Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease FS Sarfo, R Phillips, M Wansbrough‐Jones, RE Simmonds Cellular microbiology 18 (1), 17-29, 2016 | 113 | 2016 |
| Immunosuppressive Signature of Cutaneous Mycobacterium ulcerans Infection in the Peripheral Blood of Patients with Buruli Ulcer Disease R Phillips, FS Sarfo, L Guenin-Macé, J Decalf, M Wansbrough-Jones, ... The Journal of infectious diseases 200 (11), 1675-1684, 2009 | 108 | 2009 |
| Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial RO Phillips, J Robert, KM Abass, W Thompson, FS Sarfo, T Wilson, ... The Lancet 395 (10232), 1259-1267, 2020 | 98 | 2020 |
| Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial S Klis, Y Stienstra, RO Phillips, KM Abass, W Tuah, TS van der Werf PLoS Neglected Tropical Diseases 8 (3), e2739, 2014 | 81 | 2014 |
| Mycolactone diffuses into the peripheral blood of buruli ulcer patients-implications for diagnosis and disease monitoring FS Sarfo, F Le Chevalier, NG Aka, RO Phillips, Y Amoako, IG Boneca, ... PLoS neglected tropical diseases 5 (7), e1237, 2011 | 81 | 2011 |
Michael FrimpongKwame Nkrumah University of Science and TechnologyПотвърден имейл адрес: kccr.de
